Compass Pathways Plc - ADR Stock
$3.77
2.84%
yesterday
Nasdaq,
Apr 29, 10:00 pm CET
Compass Pathways Plc - ADR Stock price
$3.77
+0.91
31.82%
1M
-2.45
39.39%
6M
-0.01
0.26%
YTD
-4.34
53.51%
1Y
-5.29
58.39%
3Y
-13.23
77.82%
5Y
-13.23
77.82%
10Y
Nasdaq,
Closing price Tue, Apr 29 2025
-0.11
2.84%
Powered by
Key metrics
| Market capitalization | $258.44m |
| Enterprise Value | $125.16m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 1.67 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-178.27m |
| Free Cash Flow (TTM) Free Cash Flow | $-119.24m |
| Cash position | $165.47m |
Show more
Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
Compass Pathways Plc - ADR Stock Analysis
Unlock Scores for Free
Analyst Opinions
11 Analysts have issued a Compass Pathways Plc - ADR forecast:
Analyst Opinions
11 Analysts have issued a Compass Pathways Plc - ADR forecast:
Buy
100%
Financial data from Compass Pathways Plc - ADR
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.23 -0.23 |
-
|
|
| EBITDA | -178 -178 |
30%
30%
|
EBIT (Operating Income) EBIT | -178 -178 |
30%
30%
|
| Net Profit | -155 -155 |
31%
31%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Compass Pathways Plc - ADR Stock News
Neutral
Business Wire
●
about 20 hours ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into a strategic collaboration with HealthPort, a multi-site comprehensive community health organization. HealthPort employs an integrated model centered around social determinants...
Neutral
Business Wire
●
2 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2025, and provide an update on recent developments, on May 8, 2025. Compass management will host a c...
Positive
The Motley Fool
●
4 days ago
The field of psychedelic medicine is relatively new, and because of this, certain investors consider it to be loaded with potential. That's why even minor events in companies specializing in this can be greeted with notable share price pops.
Company Profile
| Head office | United Kingdom |
| CEO | Kabir Nath |
| Employees | 166 |
| Founded | 2016 |
| Website | compasspathways.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
